NEW YORK & WASHINGTON--(BUSINESS WIRE)--Greenleaf Health LLC today announced that Daniel G. Schultz, M.D., F.A.C.S., former Director of the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration (FDA), has joined the firm as Senior Vice President, Medical Devices and Combination Products. Greenleaf Health is a full service regulatory consulting firm that provides strategic guidance to companies regulated by the FDA and those developing innovative solutions to pressing public health problems around the globe.
In his new role, Dr. Schultz will provide strategic consulting services and work with Greenleaf clients to bring innovative devices to patients. He will be based in the firm’s newly expanded Washington, D.C. headquarters.
Dr. Schultz joins Greenleaf following a distinguished 35-year career of supporting and advancing the public health of Americans. He served for 15 years at the FDA, most recently as Director of CDRH. Prior to his time at FDA, Dr. Schultz was a member of the U.S. Public Health Service (USPHS). He has been recognized many times for his contributions and dedication to public health.
“Dan Schultz’s distinguished service at FDA, the Public Health Service and as a practicing physician and teacher enables him to bring a unique blend of experience to the Greenleaf team,” said Patrick Ronan, Founder and President of Greenleaf Health. “His addition to the firm sets Greenleaf apart with respect to depth of knowledge about FDA decision-making and critical public health and policy matters.”
Dr. Schultz began his 15-year FDA career in 1994 as a Medical Officer in the General Surgery Devices Branch of CDRH’s Office of Device Evaluation, advancing in 1995 to the position of Chief Medical Officer in the Office of Device Evaluation in the Division of Reproductive, Abdominal, ENT, and Radiological Devices. He served as Division Director from 1998 to 2001.
Dr. Schultz became Deputy Director for Clinical and Review Policy in the Office of Device Evaluation in 2001 and Director of the Office of Device Evaluation the following year. Appointed as Director of CDRH in 2004, he continued in that role until stepping down his year.
As CDRH Director, Dr. Schultz was responsible for seven FDA offices and more than 1,000 agency employees. He led the development, implementation and evaluation of regulatory policies concerning medical devices and radiation-emitting products. He also established national goals and policies to ensure that FDA and U.S. Department of Health and Human Services (HHS) objectives were met.
Prior to joining the FDA, Dr. Schultz served from 1975 to 2003 as a member of the U.S. Public Health Service (USPHS). During postings at Indian Health Service hospitals in Arizona and New Mexico, he provided medical care for people living in the Navajo Nation and Indian Pueblos. He received multiple awards for his USPHS service, including the Public Health Service Outstanding Service Medal.
In addition to his role at Greenleaf, Dr. Schultz is Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and a member of the Surgical Staff at the National Naval Medical Center, both in Bethesda, MD.
Dr. Schultz is a fellow of the American College of Surgeons and a member of the Commissioned Officers Association (COA). Dr. Schultz has written and spoken widely about regulatory, medical device and public health issues.
A graduate of the City College of New York, Dr. Schultz received his medical degree from the University of Pittsburgh. He is Board-certified in Surgery and Family Practice.
About Greenleaf Health LLC
Established in 2008, Greenleaf Health is a full service regulatory consulting firm that provides strategic guidance to companies regulated by the FDA and companies developing innovative solutions to pressing public health problems around the globe. The firm has offices in New York and Washington, DC. For further information, visit http://www.greenleafhealthllc.com
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6131930&lang=en